Literature DB >> 1833354

Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

A B Graves1, C M van Duijn, V Chandra, L Fratiglioni, A Heyman, A F Jorm, E Kokmen, K Kondo, J A Mortimer, W A Rocca.   

Abstract

A meta-analysis, involving the secondary analysis of original data from 11 case-control studies of Alzheimer's disease, is presented for alcohol consumption and cigarette smoking. Five studies included in the meta-analysis of alcohol consumption. Alcohol consumption was computed in terms of average weekly intake, measured in ounces of 'pure alcohol'. This variable was categorized into tertiles to represent low, medium and high intake. Analyses showed no excess estimated risk of Alzheimer's disease for any level of alcohol intake. Smoking was analysed in three different manners: (1) lifetime prevalence of smoking (ever/never)--this included eight studies; (2) amount smoked (less than or equal to one pack per day versus more than one pack per day)--this included seven studies; and (3) pack-years--including four studies. A statistically significant inverse association between smoking and Alzheimer's disease was observed at all levels of analysis, with a trend towards decreasing risk with increasing consumption (p(trend) = 0.0003). A propensity towards a stronger inverse relation was observed among patients with a positive family history of dementia, but the difference between this group and the group with no such history was not statistically significant. Although the observed disturbance in nicotinic receptor function in Alzheimer's disease may provide an explanation for these findings, possible biases related to the selection or survival of study subjects cannot be fully ruled out at this time. Prospective, community-based studies of incident cases of Alzheimer's disease are needed to document in detail the smoking history, age of onset of disease and survival of patients and cognitively intact people by smoking status.

Entities:  

Mesh:

Year:  1991        PMID: 1833354     DOI: 10.1093/ije/20.supplement_2.s48

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  29 in total

1.  A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study.

Authors:  D J Galanis; C Joseph; K H Masaki; H Petrovitch; G W Ross; L White
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

2.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

Review 4.  A brief overview of amyloids and Alzheimer's disease.

Authors:  Sian-Yang Ow; Dave E Dunstan
Journal:  Protein Sci       Date:  2014-07-30       Impact factor: 6.725

5.  Smoking, death, and Alzheimer disease: a case of competing risks.

Authors:  Chung-Chou H Chang; Yongyun Zhao; Ching-Wen Lee; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

6.  Mortality in relation to smoking: 40 years' observations on male British doctors.

Authors:  R Doll; R Peto; K Wheatley; R Gray; I Sutherland
Journal:  BMJ       Date:  1994-10-08

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

8.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

Authors:  C M van Duijn; L M Havekes; C Van Broeckhoven; P de Knijff; A Hofman
Journal:  BMJ       Date:  1995-03-11

9.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.